Cartesian Therapeutics (RNAC) Competitors $11.97 -1.03 (-7.92%) Closing price 04:00 PM EasternExtended Trading$11.97 0.00 (0.00%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RNAC vs. BGM, OCUL, IOVA, SNDX, WVE, COLL, ELVN, DYN, GPCR, and ETNBShould you be buying Cartesian Therapeutics stock or one of its competitors? The main competitors of Cartesian Therapeutics include Qilian International Holding Group (BGM), Ocular Therapeutix (OCUL), Iovance Biotherapeutics (IOVA), Syndax Pharmaceuticals (SNDX), Wave Life Sciences (WVE), Collegium Pharmaceutical (COLL), Enliven Therapeutics (ELVN), Dyne Therapeutics (DYN), Structure Therapeutics (GPCR), and 89bio (ETNB). These companies are all part of the "pharmaceutical products" industry. Cartesian Therapeutics vs. Qilian International Holding Group Ocular Therapeutix Iovance Biotherapeutics Syndax Pharmaceuticals Wave Life Sciences Collegium Pharmaceutical Enliven Therapeutics Dyne Therapeutics Structure Therapeutics 89bio Qilian International Holding Group (NASDAQ:BGM) and Cartesian Therapeutics (NASDAQ:RNAC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership. Does the MarketBeat Community favor BGM or RNAC? Cartesian Therapeutics received 38 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformQilian International Holding GroupN/AN/ACartesian TherapeuticsOutperform Votes3895.00% Underperform Votes25.00% Do insiders and institutionals hold more shares of BGM or RNAC? 86.9% of Cartesian Therapeutics shares are held by institutional investors. 58.7% of Qilian International Holding Group shares are held by company insiders. Comparatively, 57.9% of Cartesian Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is BGM or RNAC more profitable? Qilian International Holding Group has a net margin of 0.00% compared to Cartesian Therapeutics' net margin of -510.72%. Company Net Margins Return on Equity Return on Assets Qilian International Holding GroupN/A N/A N/A Cartesian Therapeutics -510.72%N/A -6.03% Do analysts prefer BGM or RNAC? Cartesian Therapeutics has a consensus price target of $42.14, suggesting a potential upside of 252.07%. Given Cartesian Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Cartesian Therapeutics is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cartesian Therapeutics 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has stronger valuation & earnings, BGM or RNAC? Qilian International Holding Group has higher earnings, but lower revenue than Cartesian Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQilian International Holding Group$25.10M40.64-$1.44MN/AN/ACartesian Therapeutics$38.91M7.97-$219.71M-$52.83-0.23 Which has more risk and volatility, BGM or RNAC? Qilian International Holding Group has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, Cartesian Therapeutics has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Does the media refer more to BGM or RNAC? In the previous week, Cartesian Therapeutics had 6 more articles in the media than Qilian International Holding Group. MarketBeat recorded 7 mentions for Cartesian Therapeutics and 1 mentions for Qilian International Holding Group. Qilian International Holding Group's average media sentiment score of 1.87 beat Cartesian Therapeutics' score of 0.70 indicating that Qilian International Holding Group is being referred to more favorably in the media. Company Overall Sentiment Qilian International Holding Group Very Positive Cartesian Therapeutics Positive SummaryQilian International Holding Group and Cartesian Therapeutics tied by winning 7 of the 14 factors compared between the two stocks. Remove Ads Get Cartesian Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RNAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RNAC vs. The Competition Export to ExcelMetricCartesian TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$310.11M$6.32B$5.33B$7.57BDividend YieldN/A3.23%5.11%4.32%P/E Ratio-0.236.7921.7317.81Price / Sales7.97225.93379.1994.60Price / CashN/A65.6738.1534.64Price / Book-0.155.866.464.00Net Income-$219.71M$141.86M$3.20B$247.23M7 Day Performance25.74%8.98%6.54%7.26%1 Month Performance-24.24%-12.65%-8.55%-6.26%1 Year Performance-36.97%-11.99%10.33%-0.18% Cartesian Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RNACCartesian Therapeutics1.8677 of 5 stars$11.97-7.9%$42.14+252.1%-33.0%$310.11M$38.91M-0.2364BGMQilian International Holding GroupN/A$10.62-0.9%N/AN/A$1.03B$25.10M0.00298Positive NewsOCULOcular Therapeutix3.4113 of 5 stars$6.30-0.9%$16.38+159.9%-5.3%$1.00B$63.72M-4.77230Gap DownIOVAIovance Biotherapeutics4.2578 of 5 stars$3.03+1.0%$20.25+568.3%-72.4%$993.47M$164.07M-2.03500Analyst ForecastNews CoverageHigh Trading VolumeSNDXSyndax Pharmaceuticals3.4858 of 5 stars$11.01-2.1%$36.20+228.8%-48.3%$947.34M$23.68M-3.03110Gap DownWVEWave Life Sciences4.1802 of 5 stars$5.80-3.8%$22.60+289.7%+3.4%$890.22M$108.30M-5.23240Short Interest ↑Analyst RevisionCOLLCollegium Pharmaceutical4.1648 of 5 stars$27.38-2.7%$43.60+59.2%-25.1%$879.77M$631.45M11.80210News CoveragePositive NewsGap DownELVNEnliven Therapeutics2.5509 of 5 stars$17.87-4.4%$38.75+116.8%-18.5%$875.70MN/A-9.4150News CoverageDYNDyne Therapeutics3.73 of 5 stars$7.49-9.5%$47.46+533.7%-71.1%$847.28MN/A-2.10100Positive NewsGPCRStructure Therapeutics2.5699 of 5 stars$14.31-5.4%$81.29+468.0%-51.8%$820.58MN/A-19.34136News CoverageETNB89bio2.5806 of 5 stars$5.49-4.9%$27.56+401.9%-39.7%$801.45MN/A-1.8940Short Interest ↑News CoverageGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies BGM Competitors OCUL Competitors IOVA Competitors SNDX Competitors WVE Competitors COLL Competitors ELVN Competitors DYN Competitors GPCR Competitors ETNB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RNAC) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RNAC Stock Free RNAC Stock Alerts